Paying the Iron Price: Liver Iron Homeostasis and Metabolic Disease

被引:8
|
作者
Ameka, Magdalene [1 ]
Hasty, Alyssa H. [1 ,2 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA
[2] VA Tennessee Valley Healthcare Syst, Nashville, TN USA
关键词
SOLUBLE TRANSFERRIN RECEPTOR; OXYGENASE-1 GENE PROMOTER; TYPE-2; DIABETES-MELLITUS; KUPFFER CELL ACTIVATION; NECROSIS-FACTOR-ALPHA; HEME OXYGENASE-1; INSULIN-RESISTANCE; FATTY LIVER; OXIDATIVE STRESS; SCAVENGER RECEPTOR;
D O I
10.1002/cphy.c210039
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Iron is an essential metal element whose bioavailability is tightly regulated. Under normal con-ditions, systemic and cellular iron homeostases are synchronized for optimal function, based on the needs of each system. During metabolic dysfunction, this synchrony is lost, and markers of systemic iron homeostasis are no longer coupled to the iron status of key metabolic organs such as the liver and adipose tissue. The effects of dysmetabolic iron overload syndrome in the liver have been tied to hepatic insulin resistance, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis. While the existence of a relationship between iron dysregulation and metabolic dysfunction has long been acknowledged, identifying correlative relationships is complicated by the prognostic reliance on systemic measures of iron homeostasis. What is lacking and perhaps more informative is an understanding of how cellular iron homeostasis changes with metabolic dysfunction. This article explores bidirectional relationships between different proteins involved in iron homeostasis and metabolic dysfunction in the liver. (c) 2022 American Physiological Society. Compr Physiol 12:3641-3663, 2022.
引用
收藏
页码:3641 / 3663
页数:23
相关论文
共 50 条
  • [21] Iron homeostasis and iron toxicity
    Crichton, RR
    Ward, RJ
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 86 (01) : 36 - 36
  • [22] Metabolic capacity regulates iron homeostasis in endothelial cells
    Carraway, M. S.
    Suliman, H. B.
    Madden, M. C.
    Piantadosi, C. A.
    Ghio, A. J.
    FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 (11) : 1662 - 1669
  • [23] Iron, metabolic syndrome, nonalcoholic fatty liver disease and carotid atherosclerosis
    Mascitelli, Luca
    Pezzetta, Francesca
    Goldstein, Mark R.
    ATHEROSCLEROSIS, 2009, 205 (01) : 39 - 40
  • [24] The Role of Iron and Iron Overload in Chronic Liver Disease
    Milic, Sandra
    Mikolasevic, Ivana
    Orlic, Lidija
    Devcic, Edita
    Starcevic-Cizmarevic, Nada
    Stimac, Davor
    Kapovic, Miljenko
    Ristic, Smiljana
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2144 - 2151
  • [25] Iron and Neurodegeneration: From Cellular Homeostasis to Disease
    Batista-Nascimento, Liliana
    Pimentel, Catarina
    Menezes, Regina Andrade
    Rodrigues-Pousada, Claudina
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2012, 2012
  • [26] Haptoglobin polymorphisms and iron homeostasis in health and in disease
    Van Vlierberghe, H
    Langlois, M
    Delanghe, J
    CLINICA CHIMICA ACTA, 2004, 345 (1-2) : 35 - 42
  • [27] The impact of host iron homeostasis on disease Preface
    Connor, James R.
    Ghio, Andrew J.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (07):
  • [28] Iron Homeostasis Disorder and Alzheimer's Disease
    Peng, Yu
    Chang, Xuejiao
    Lang, Minglin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [29] Impaired iron homeostasis in Parkinson's disease
    Double, KL
    Gerlach, M
    Youdim, MBH
    Riederer, P
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 8, 2000, 8 : 37 - 58
  • [30] Iron homeostasis
    Andrews, Nancy C.
    Schmidt, Paul J.
    ANNUAL REVIEW OF PHYSIOLOGY, 2007, 69 : 69 - 85